Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company ...
Organigram stock has performed well this year, despite an equity raise and a temporary pullback caused by Tilray's poor financial report. The fiscal Q1 report showed a revenue shortfall, particularly ...
Hosted on MSN
Organigram appoints new CEO to drive global growth
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results